Collectively, our findings provide not only new insights into the role of SPON1 in cancer progression but also a novel and effective therapeutic approach for the eradication of PDAC, which remains a life‐threatening disease without an effective, targeted therapeutic strategy. Here, SPON1 is linked to cancer.